We identified de novo truncating mutations in ARID1B in three individuals with Coffin-Siris syndrome (CSS) by exome sequencing. Array-based copy-number variation (CNV) analysis in 2,000 individuals with intellectual disability revealed deletions encompassing ARID1B in 3 subjects with phenotypes partially overlapping that of CSS. Taken together with published data, these results indicate that haploinsufficiency of the ARID1B gene, which encodes an epigenetic modifier of chromatin structure, is an important cause of CSS and is potentially a common cause of intellectual disability and speech impairment.
ARID1B variants have been submitted to the Leiden Open Variation Database (see URLs). Using the sequence analysis pipeline from the Genome Analysis Toolkit (GATK) 5, 6 , we identified 12,722-14,642 exonic and/or splice-site variants per individual. Filtering steps using variant databases (dbSNP132 and the 1000 Genomes Project database) and selection for coding regions revealed variants in 34 genes that were shared by all three affected individuals. After filtering for recessive inheritance (discarding all genes with only one heterozygous variant), no gene was found to be in agreement with a recessive inheritance model in all three cases. Accepting a dominant inheritance mechanism, we queried heterozygous and de novo variants and identified ARID1B as the only affected gene in all cases (Supplementary Table 3 ). All variants truncated the ARID1B reading frame (two nonsense variants: c.5329A>T (p.Lys1777*) and c.3223C>T (p.Arg1075*) and one frameshift: c.4619_4628del (p.Gln1541Argfs*35)) ( Table 1) . The mutations were validated using Sanger sequencing and shown to occur de novo in all three individuals (Supplementary Fig. 2 ). With it not previously being possible to rule out an autosomal recessive inheritance mechanism, the parents of an individual affected with CSS received a recurrence risk of 10% (ref. 7) . The identification of de novo mutations in ARID1B in CSS cases allowed us to reduce this risk to 1-2% (ref. 8) .
We queried our in-house database of individuals screened for intellectual disability for potential CNVs including ARID1B. The screened cohort consisted of individuals with intellectual disability and/or congenital malformations (syndromic and non-syndromic) who were referred for array-based CNV analysis. In this analysis, we identified 3 subjects out of 2,000 with a deletion affecting ARID1B (Fig. 1 Figure 1 Facial features of all subjects. Top, left to right: subject 1 at 4.5 years, subject 2 at 2.5 years and subject 3 at 3 years. Bottom, left to right: subject 4 at 3.5 years, subject 5 at 45 years and subject 6 at 3.5 years. All subjects share coarse facial features, thick eyebrows and broad nasal tips. For further details, see Supplementary Table 1 . The parents or legal guardians of all affected individuals gave consent for publication of the clinical photographs.
and ZDHHC14 loci, while subject 6 had a de novo deletion of 0.88 Mb encompassing the same genes as in subject 5. Analysis of the phenotypes of these individuals showed that, similar to our subjects with CSS, they had moderate-to-severe intellectual disability and severe speech delay. These individuals also had facial similarities with the subjects with CSS ( Fig. 1) but lacked some typical CSS abnormalities, such as hypoplastic or absent fingernails or toenails. A possible diagnosis of these individuals with CSS was considered only for subject 4 because of her hypoplastic fingernails (Supplementary Table 1 ). A previous study described eight individuals with intellectual disability and speech impairment with haploinsufficiency of ARID1B (in one subject the gene was disrupted by a reciprocal translocation) 9 . Disruption of ARID1B, as well as de novo intragenic deletion, has also been reported in individuals with either corpus callosum agenesis or autism 9, 10 . Although the sizes of the published deletions range from <1 Mb to >14 Mb, the phenotypes of the affected individuals largely overlap with those of our CSS cases, with the exception of the fifth finger abnormalities typical to CSS. Disruption of ARID1B therefore seems to be the main driver of the observed CSS phenotype, and a diagnosis of CSS should be considered in all individuals with intellectual disability and speech impairment, particularly when these clinical features occur in combination with agenesis of the corpus callosum. On the basis of these findings, we conclude that haploinsufficiency of ARID1B is likely to be an important cause of CSS.
The publicly available Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources (DECIPHER) contains 12 individuals with haploinsufficiency of ARID1B (including the 3 described here and the 8 that were described previously 9 ). As all deletions and mutations published thus far have been de novo, disease penetrance is expected to be high. No truncating or splice-site mutations are present in the 1000 Genomes Project database or in the ~5,400 exomes of the Exome Variant Server. However, the Database of Genomic Variants includes two deletions that encompass exon 1 and exons 2-20 of the ARID1B gene, respectively. This could signify reduced penetrance, but an alternative explanation could be that these deletions represent a technical artifact. Both deletions were not validated using alternative methods.
Along with ARID1A, ARID1B encodes an AT-rich interactive domain (ARID) protein, a subunit of the Brahma-associated factor (BAF) complex. BAF is one of the two main components of the SWItch/sucrose nonfermentable (SWI/SNF)-like chromatin remodeling complex, which acts as an epigenetic modifier by altering chromatin structure, thereby facilitating the access of transcription factors to DNA. ARID1A and ARID1B proteins have antagonistic functions and are both important for cell cycle regulation. Although ARID1B is predominantly expressed in differentiated cell types, it has also been suggested to be involved in early development of the brain 11 .
ARID1A is more abundantly expressed in embryonic tissue, and somatic mutations in this gene have recently been associated with gastric cancer 12 . It was also noted recently that histone modifying proteins seem to have a dual role, functioning both in developmental disorders and malignancies 13 . One could hypothesize that activating mutations in ARID1A might give a clinical phenotype similar to CSS.
In conclusion, CSS can be added to a growing list of syndromes characterized by congenital malformations and intellectual disability that are caused by mutations in genes that encode modifiers of chromatin structure 14, 15 . b r i e F c o m m u n i c a T i o n S npg
